Corcept Therapeutics Incorporated (CORT) vs Encompass Health Corporation (EHC)
A side-by-side comparison of Corcept Therapeutics Incorporated and Encompass Health Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CORT
Corcept Therapeutics Incorporated
$119.63HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
EHC
Encompass Health Corporation
$122.72HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — CORT vs EHC
growth of $100 · dividends reinvested · last 10yCORT +1754.6% (+33.9%/yr)EHC +326.5% (+15.6%/yr)CORT compounded faster over this window
CORT EHC
CORT vs EHC: by the numbers
- •CORT is the larger company ($12.93B vs $12.17B market cap).
- •EHC trades at the lower trailing earnings multiple (19.99 vs 284.83 P/E), one valuation lens rather than an overall verdict.
- •EHC converts more revenue to profit (10.01% vs 6.61% net margin).
- •CORT grew revenue faster over the past five years (19.35% vs 4.81% CAGR).
- •EHC pays a dividend (0.63% yield), while CORT has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CORT | EHC |
|---|---|---|
| P/E ratio | 284.83 | 19.99 |
| Forward P/E | N/A | 20.07 |
| PEG ratio | N/A | 1.41 |
| P/S ratio | 15.57 | 1.96 |
| P/B ratio | 18.32 | 4.69 |
| EV / EBITDA | 1453.84 | 10.19 |
| FCF yield | 0.83% | 3.40% |
Profitability
| Metric | CORT | EHC |
|---|---|---|
| Gross margin | 98.30% | 95.71% |
| Operating margin | 0.77% | 18.00% |
| Net margin | 6.61% | 10.01% |
| ROE | 7.78% | 23.91% |
| ROIC | 0.87% | 13.42% |
Dividends
| Metric | CORT | EHC |
|---|---|---|
| Dividend yield | N/A | 0.63% |
| Payout ratio | N/A | 12.38% |
Growth (annualized)
| Metric | CORT | EHC |
|---|---|---|
| Revenue CAGR (5Y) | 19.35% | 4.81% |
| EPS CAGR (5Y) | 0.64% | 14.39% |
| FCF CAGR (5Y) | -4.40% | 0.28% |
| Total return CAGR (5Y) | 43.90% | 17.12% |
Frequently asked
- Which has the lower trailing P/E, CORT or EHC?
- EHC has the lower trailing P/E: CORT trades at 284.83 and EHC at 19.99. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, CORT or EHC?
- Over the past five years, CORT grew revenue faster — CORT at a 19.35% CAGR versus EHC at 4.81%.
- Does CORT or EHC pay a bigger dividend?
- EHC pays a dividend (0.63% yield), while CORT has no payments in the available dividend history.
- Is CORT or EHC more profitable?
- EHC runs the higher net margin — CORT at 6.61% versus EHC at 10.01%.
- How have CORT and EHC total returns compared?
- Over the past 10 years, CORT delivered 33.70% and EHC delivered 15.79% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Corcept Therapeutics P/E ratioEncompass Health P/E ratioEncompass Health dividend yieldCorcept Therapeutics ROEEncompass Health ROECorcept Therapeutics operating marginEncompass Health operating marginCorcept Therapeutics revenue growthEncompass Health revenue growthCorcept Therapeutics free cash flowEncompass Health free cash flow
Corcept Therapeutics & Encompass Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.